NAS:IDXG () Also Trade In: Germany

Interpace Biosciences Inc $ 6.04 -0.13 (-2.11%)

Volume:
128,858
Avg Vol (1m):
510,394
Market Cap $:
24.38 Mil
Enterprise Value $:
61.54 Mil
P/E (TTM):
0.00
P/B:
3.56
Warning! GuruFocus has detected 4 Severe warning signs with IDXG. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Interpace Biosciences Inc () from 1998 to Aug 13 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Interpace Biosciences stock (IDXG) PE ratio as of Aug 13 2020 is 0. More Details

Interpace Biosciences PE Ratio (TTM) Chart

EMBED

Interpace Biosciences PE Ratio (TTM) Historical Data

Total 1274
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Interpace Biosciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-08-130.0 2020-06-110.0
2020-08-120.0 2020-06-100.0
2020-08-110.0 2020-06-090.0
2020-08-100.0 2020-06-080.0
2020-08-070.0 2020-06-050.0
2020-08-060.0 2020-06-040.0
2020-08-050.0 2020-06-030.0
2020-08-040.0 2020-06-020.0
2020-08-030.0 2020-06-010.0
2020-07-310.0 2020-05-290.0
2020-07-300.0 2020-05-280.0
2020-07-290.0 2020-05-270.0
2020-07-280.0 2020-05-260.0
2020-07-270.0 2020-05-250.0
2020-07-240.0 2020-05-220.0
2020-07-230.0 2020-05-210.0
2020-07-220.0 2020-05-200.0
2020-07-210.0 2020-05-190.0
2020-07-200.0 2020-05-180.0
2020-07-170.0 2020-05-150.0
2020-07-160.0 2020-05-140.0
2020-07-150.0 2020-05-130.0
2020-07-140.0 2020-05-120.0
2020-07-130.0 2020-05-110.0
2020-07-100.0 2020-05-080.0
2020-07-090.0 2020-05-070.0
2020-07-080.0 2020-05-060.0
2020-07-070.0 2020-05-050.0
2020-07-060.0 2020-05-040.0
2020-07-030.0 2020-05-010.0
2020-07-020.0 2020-04-300.0
2020-07-010.0 2020-04-290.0
2020-06-300.0 2020-04-280.0
2020-06-290.0 2020-04-270.0
2020-06-260.0 2020-04-240.0
2020-06-250.0 2020-04-230.0
2020-06-240.0 2020-04-220.0
2020-06-230.0 2020-04-210.0
2020-06-220.0 2020-04-200.0
2020-06-190.0 2020-04-170.0
2020-06-180.0 2020-04-160.0
2020-06-170.0 2020-04-150.0
2020-06-160.0 2020-04-140.0
2020-06-150.0 2020-04-130.0
2020-06-120.0 2020-04-100.0

Interpace Biosciences PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Medical Diagnostics & Research » NAICS : 541380 NAICS : 8099
Traded in other countries PF42.Germany IDXG.USA
Address 300 Interpace Parkway, Building C, Morris Corporate Center 1, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc is engaged in providing personalized medicines. It also offers specialized services along the therapeutic value chain to therapeutic applications.